Health Research

Health Research Library

Search

The ameliorative role of cranberry extract use on hematological changes induced by lead acetate in rats.

Posted
Authors
El-Belbasy, H., Hussein, M., El-Ghitany, M.
Journal
Zagazig Veterinary Journal 2021. 49(1):102-113.
Abstract

Lead poisonousness is a widely recognized type of heavy metal poisoning in humans and animals. So, this study aimed to assess the ameliorative role of cranberry extract use on hematological changes induced by lead acetate in rats. A total number of 40 adult male albino rats weighing approximately 200 +or- 20 g were randomly assigned into four groups; Normal control group, group 2; Positive control, lead acetate at a dose of (50 PPM) for 45 days, group 3; Lead acetate at a dose of (50 PPM) then Cranberry extract (75 mg/kg) for 45 days also group 4; Lead acetate (50 PPM) then Cranberry extract (150 mg/kg) for 45 days. Blood samples were collected in EDTA tubes for hematological examinations. Oral administration of lead acetate (50 PPM) significantly decreased total erythrocyte count, hemoglobin, packed cell volume and mean cell volume levels in comparison with the normal control group (P< 0.0001). Addition of cranberry extract at a dose of 75 and 150 mg/kg significantly increased the total erythrocyte count, hemoglobin, packed cell volume and mean cell volume levels in comparison with the positive control group (P< 0.0001). Oral administration of lead acetate (50 PPM) significantly increased total leukocytes count, lymphocyte, neutrophils, eosinophil and monocytes count in comparison with the normal control group (P< 0.0001). Addition of cranberry extract at a dose of 75 and 150 mg/kg significantly decreased the total leukocytes count, lymphocyte, neutrophils, eosinophil and monocytes count in comparison with the positive control group (P< 0.0001). Our results clearly indicate that cranberry extract ameliorates hematological changes in lead acetate-treated rats